These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3050774)

  • 1. [The effect of vitamin A therapy on the immune function and lipid peroxidation in patients with Sjögren syndrome].
    Szöcsik K; Rhenso GC; Cao VV; Mézes M; Szongoth M; Gergely P
    Orv Hetil; 1988 Sep; 129(39):2091-4. PubMed ID: 3050774
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of vitamin A treatment on immune reactivity and lipid peroxidation in patients with Sjögren's syndrome.
    Szöcsik K; González-Cabello R; Vien CV; Mézes M; Szongoth M; Gergely P
    Clin Rheumatol; 1988 Dec; 7(4):514-9. PubMed ID: 3246135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternate-day steroid therapy for patients with primary Sjögren's syndrome.
    Tabbara KF; Frayha RA
    Ann Ophthalmol; 1983 Apr; 15(4):358-61. PubMed ID: 6660708
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased human paraoxonase-1 activity in patients with Sjögren's syndrome.
    Szántó A; Harangi M; Seres I; Paragh G; Zeher M
    Int Immunol; 2010 Jul; 22(7):605-9. PubMed ID: 20497955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thymosin in the treatment of Sjogren's syndrome].
    Wen ZX
    Zhonghua Kou Qiang Ke Za Zhi; 1986 Jul; 21(4):219-20, 254. PubMed ID: 3471407
    [No Abstract]   [Full Text] [Related]  

  • 6. [Scleroderma and Gougerot-Sjögren syndrome. Effect of methotrexate therapy].
    Welin J; Grolleau JY; Barrière H
    Sem Hop Ther; 1973 Jan; 49(1):37-41. PubMed ID: 4712023
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab therapy in primary Sjögren's syndrome.
    Alcântara C; Gomes MJ; Ferreira C
    Ann N Y Acad Sci; 2009 Sep; 1173():701-5. PubMed ID: 19758218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of physalaemin in the treatment of Sjogren's disease].
    Tamborini A; Perrotta P
    Ann Ottalmol Clin Ocul; 1969 Dec; 95(12):945-60. PubMed ID: 5408524
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.
    Ahmadi-Simab K; Lamprecht P; Nölle B; Ai M; Gross WL
    Ann Rheum Dis; 2005 Jul; 64(7):1087-8. PubMed ID: 15958765
    [No Abstract]   [Full Text] [Related]  

  • 10. Sjogren's syndrome. When your tissues dry out.
    Mayo Clin Health Lett; 2006 Jul; 24(7):7. PubMed ID: 16865802
    [No Abstract]   [Full Text] [Related]  

  • 11. Stopping traffic in Sjögren's syndrome.
    Cohen PL
    Arthritis Rheum; 2006 Apr; 54(4):1061-2. PubMed ID: 16572440
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on killer cells (K-cells) in peripheral blood in Sjögren's syndrome (author's transl)].
    Ichikawa Y; Sasao K; Takaya M; Arimori S
    Ryumachi; 1980 Sep; 20(4):253-9. PubMed ID: 7444663
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lymphocyte cytotoxicity actions (antibody-dependent cell-mediated cytotoxicity and NK function) in Sjogren's disease].
    Shigehara T; Goto M; Takeuchi A; Hashimoto A; Tanimoto K
    Nihon Rinsho; 1983; 41(2):449-51. PubMed ID: 6865015
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sjögren's disease].
    Bijl M; Panders AK; Vissink A; Nikkels PG; Kallenberg CG
    Ned Tijdschr Geneeskd; 1994 May; 138(21):1049-52. PubMed ID: 8202174
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody-dependent cell-mediated cytotoxicity by peripheral blood mononuclear cells from patients with Sjögren's syndrome, with special reference to differentiation from phagocytic activity.
    Ichikawa Y; Takaya M; Arimori S
    Tokai J Exp Clin Med; 1980 Jan; 5(1):83-90. PubMed ID: 7385266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reticuloendothelial Fc receptor function in patients with Sjogren's syndrome.
    O'Sullivan MM; Walker DM; Williams BD
    Clin Exp Immunol; 1985 Sep; 61(3):483-8. PubMed ID: 4075586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppression in Sjogren's syndrome with a pseudo-leukemic lymphocyte reaction].
    Orlowski Z; Jedrzejewska T
    Pol Tyg Lek; 1970 Oct; 25(42):1588-9. PubMed ID: 5476524
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between the occurrence of anti-SSA, anti-SSB autoantibodies and HLA class II alleles from the aspect of in vitro inhibitory effect of glucocorticosteroid on the antibody-dependent cellular cytotoxicity in patients with primary Sjögren's syndrome.
    Kovács A; Szekeres E; Berek L; Endreffy E; Kovács L; Makula E; Eller J; Pokorny G; Petri IB
    Acta Microbiol Immunol Hung; 2000; 47(4):421-31. PubMed ID: 11056762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is Sjögren's syndrome and why is it important?
    Talal N
    J Rheumatol Suppl; 2000 Dec; 61():1-3. PubMed ID: 11128697
    [No Abstract]   [Full Text] [Related]  

  • 20. [ADCC (antibody-dependent cell-mediated cytotoxicity) in Sjogren's disease].
    Suzuki T; Imai F; Ishibashi T; Sekiya S
    Nihon Rinsho; 1983; 41(2):444-6. PubMed ID: 6865014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.